4//SEC Filing
Joshi Abhay 4
Accession 0001628280-20-014240
CIK 0001479290other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 8:31 PM ET
Size
6.3 KB
Accession
0001628280-20-014240
Insider Transaction Report
Form 4
Joshi Abhay
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2020-09-30$25.14/sh−7,382$185,583→ 111,950 total - Award
Common Stock
2020-09-30+17,500→ 119,332 total
Footnotes (2)
- [F1]Represents shares of Common Stock received upon partial settlement of a performance share award (the "PSA") on September 30, 2020.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on September 30, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the PSA.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001359089
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 8:31 PM ET
- Size
- 6.3 KB